Small cell lung cancer extensive stage

• Durvalumab (MEDI4736) in combination with consolidative radiochemotherapy and ablative stereotactic radiotherapy in extensive stage SCLC Pending
  2024-517937-41-00 4 "extensive stage small cell lung cancer (SCLC)"
• A clinical study to investigate the efficacy of tarlatamab in people with extensive-stage small cell lung cancer (ES-SCLC) whose cancer has … Pending
  2025-522288-13-00 4 "Patients with pretreated extensive-stage small cell lung can"
• A clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer Pending
  2025-523276-23-00 7 "Extensive stage small cell lung cancer"
• A Study to Learn about the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive Stage Sma … Pending
  2025-523522-41-00 10 "Extensive-Stage Small Cell Lung Cancer"
• Study of IBI3009 alone or in combination with other therapies for extensive-stage small cell lung cancer Pending
  2025-523972-21-00 7 "Extensive-Stage Small Cell Lung Cancer"
• Phase 1b Study of Tarlatamab + ZL-1310 +/- Anti-PD-L1 in Small Cell Lung Cancer Recruiting
  2025-522888-15-00 3 2026-05-27 "Small Cell Lung Cancer"
• A single-arm phase II-study to confirm efficacy and feasibility of tarlatamab treatment in patients with extensive stage small-cell lung can … Recruiting
  2025-522437-65-00 4 2026-03-06 "small-cell lung cancer"
• Study assessing the efficacy of etoposide free chemotherapy plus durvalumab in first line extensive disease Small Cell Lung Cancer Recruiting
  2023-504670-38-00 4 2023-11-17 "Extensive disease Small Cell Lung Cancer"
• A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab. Recruiting
  2024-513185-19-00 9 2022-07-13 "Extensive stage small cell lung cancer (ES-SCLC)"
• Safety and efficacy of BNT327, an investigational therapy, in combination with chemotherapy for patients with untreated small-cell lung canc … Recruiting
  2024-515765-34-00 5 2026-02-04 "English First-line extensive-stage small-cell lung cancer (E"
• A Phase 1b/2, Study of I-DXd in Combination with Atezolizumab with or without Carboplatin in First-line ES‑SCLC Recruiting
  2023-509629-36-00 9 2025-10-29 "Extensive-stage Small Cell Lung Cancer (ES-SCLC)"
• Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer Recruiting
  2024-515884-69-00 5 2025-07-16 "Extensive Stage Small Cell Lung Cancer (ES-SCLC)"
• Subcutaneous Tarlatamab in Subjects with Extensive Stage Small Cell Lung Cancer (DeLLphi-308) Recruiting
  2024-511838-12-00 3 2024-11-22 "Extensive Stage Small Cell Lung Cancer (DeLLphi-308)"
• Maintenance of durvalumab and olaparib after standard 1st line treatment (carboplatin/ cisplatin, etoposide, durvalumab) in HRD positive ext … Recruiting
  2024-512373-27-00 4 2024-09-30 "Advanced/inoperable or metastatic small-cell lung cancer"
• A clinical study to test the effect of niraparib and immunotherapy, for patients with small cell lung cancer (SCLC) that is positive for SLF … Recruiting
  2022-502092-33-00 4 2024-05-31 "Extensive-disease small cell lung cancer and high SLFN11-exp"
• A Study Evaluating the Overall Survival of Patients with Extensive Stage Small Cell Lung Cancer Receiving Trilaciclib or Placebo prior to To … Recruiting
  2022-502357-34-00 5 2023-09-27 "Extensive Stage Small Cell Lung Cancer"
• Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLL … Recruitment ended
  2024-520050-38-00 5 2025-09-18 "Extensive stage small cell lung cancer (ES-SCLC). "
• BMS-986489 (BMS-986012 + Nivolumab Fixed Dose Combination) with Chemotherapy vs Atezolizumab with Chemotherapy as First-line Therapy in Part … Recruitment ended
  2024-515740-23-00 5 2025-03-25 "Extensive-Stage Small Cell Lung Cancer (ES-SCLC)"
• Study Comparing Tarlatamab and Durvalumab versus Durvalumab Alone in First Line ES-SCLC Following Platinum, Etoposide and Durvalumab (DeLLph … Recruitment ended
  2023-505989-29-00 5 2024-11-21 "Extensive stage small cell lung cancer (ES-SCLC)"
• DAREONTM-9: A study to test how well different doses of BI 764532 are tolerated by people with small cell lung cancer when taken together w … Recruitment ended
  2023-506007-26-00 3 2024-01-15 "relapsed/refractory extensive stage - small cell lung cancer"
• DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small … Recruitment ended
  2023-506008-20-00 3 2024-01-11 "Extensive-stage small cell lung carcinoma (ES-SCLC)"
• Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe Recruitment ended
  2023-503574-20-00 4 2023-11-29 "Lung Cancer"
• Study of pembrolizumab, lenvatinib and chemotherapy combination in first line lung cancer Recruitment ended
  2024-511412-25-00 4 2022-11-07 "First line treatment for extensive-stage small cell lung can"
• I-DXd in Patients With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Recruitment ended
  2024-512368-79-00 4 2022-10-10 "Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC)"

Showing 1–24 of 34 trials